Han Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Han Yu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Chao Liu
School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China
1 shared publication- Chenlan Li
State Key Laboratory of Biocontrol, School of Life Sciences Sun Yat‐sen University Guangzhou China
1 shared publication Chunyan Wu
Institute of Clinical Epidemiology and Evidence-based Medicine, Tongji University School of Medicine, 1239 Siping Road, Shanghai, 200092, China
1 shared publicationFenghua Zhang
School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China
1 shared publicationJianfei Wang
Department of Nephrology, South of Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
1 shared publication- Jue Li
Clinical Center for Intelligent Rehabilitation Research, Shanghai YangZhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), Tongji University School of Medicine, Tongji University, Shanghai, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 283, 114709
miRNA and miRNA target genes in intervention effect of Zhuyu pill on cholestatic rat model
- 1 January 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 283, 114709
Open AccessmiRNA and miRNA target genes in intervention effect of Zhuyu pill on cholestatic rat model
- Open Access
- 10 August 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-10
Epigallocatechin-3-gallate inhibits H2O2-induced apoptosis in Mouse Vascular Smooth Muscle Cells via 67kD Laminin Receptor
Epigallocatechin-3-gallate (EGCG) is one of the major polyphenolic compounds present in green tea extracts and has been used as a potential drug for the treatment of numerous diseases. The present study aimed to elucidate the role and mechanism of EGCG in protecting against H2O2-induced apoptosis in mouse vascular smooth muscle cells (VSMCs). VSMCs were pretreated with various concentrations of EGCG for 2 hours prior to treatment with H2O2. Treatment with H2O2 significantly decreased the cell viability and induced apoptosis of VSMCs, which were attenuated by pretreatment with EGCG. In particular, EGCG pretreatment significantly inhibited the H2O2-induced upregulation of cleaved forms of caspase-3, caspase-8, and caspase-9, Bax, CathepsinD, and downregulation of Bcl-2. Moreover, the antioxidation effect of EGCG on VSMCs was determined to be associated with the 67kD laminin receptor (67LR). Our results demonstrated that EGCG improved cell viability and protected VSMCs against oxidative stress through both extrinsic and intrinsic pathways, while 67LR is likely to be an active and key receptor of EGCG. These findings provide a novel molecular mechanism of EGCG in inhibiting H2O2-induced apoptosis in VSMCs, as well as its function in preventing the development of atherosclerosis.
- 10 August 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-10
Open AccessEpigallocatechin-3-gallate inhibits H2O2-induced apoptosis in Mouse Vascular Smooth Muscle Cells via 67kD Laminin Receptor
Epigallocatechin-3-gallate (EGCG) is one of the major polyphenolic compounds present in green tea extracts and has been used as a potential drug for the treatment of numerous diseases. The present study aimed to elucidate the role and mechanism of EGCG in protecting against H2O2-induced apoptosis in mouse vascular smooth muscle cells (VSMCs). VSMCs were pretreated with various concentrations of EGCG for 2 hours prior to treatment with H2O2. Treatment with H2O2 significantly decreased the cell viability and induced apoptosis of VSMCs, which were attenuated by pretreatment with EGCG. In particular, EGCG pretreatment significantly inhibited the H2O2-induced upregulation of cleaved forms of caspase-3, caspase-8, and caspase-9, Bax, CathepsinD, and downregulation of Bcl-2. Moreover, the antioxidation effect of EGCG on VSMCs was determined to be associated with the 67kD laminin receptor (67LR). Our results demonstrated that EGCG improved cell viability and protected VSMCs against oxidative stress through both extrinsic and intrinsic pathways, while 67LR is likely to be an active and key receptor of EGCG. These findings provide a novel molecular mechanism of EGCG in inhibiting H2O2-induced apoptosis in VSMCs, as well as its function in preventing the development of atherosclerosis.
- 1 December 2016
- Published by Elsevier in Marine Genomics
- Vol. 30, 93-95
Genome sequence of an inducible phage in Rhodovulum sp. P5 isolated from the shallow-sea hydrothermal system
- 1 December 2016
- Published by Elsevier in Marine Genomics
- Vol. 30, 93-95
Genome sequence of an inducible phage in Rhodovulum sp. P5 isolated from the shallow-sea hydrothermal system